References
- Aina, O. H., T. C. Sroka, M. L. Chen and K. S. Lam. 2002. Therapeutic cancer targeting peptides. Biopolymers 66, 184-199. https://doi.org/10.1002/bip.10257
- Atkins, J. F., R. B. Weiss, S. Thompson and R. F. Gesteland. 1991. Towards a genetic dissection of the basis of triplet decoding, and its natural subversion: programmed reading frame shifts and hops. Annu. Rev. Genet. 25, 201-228. https://doi.org/10.1146/annurev.ge.25.120191.001221
- Carcamo, J., M. W. Ravera, R. Brissette, O. Dedova, J. R. Beasley, A. Alam-Moghe, C. Wan, A. Blume and W. Mandecki. 1998. Unexpected frameshifts from gene to expressed protein in a phage-displayed peptide library. Proc. Natl. Acad. Sci. USA. 95, 11146-11151. https://doi.org/10.1073/pnas.95.19.11146
- Chiu, S. J., S. Liu, D. Perrotti, G. Marcucci and R. J. Lee. 2006. Efficient delivery of a Bcl-2-specific antisense oligodeoxyribonucleotide (G3139) via transferrin receptor-targeted liposomes. J. Control. Release 112, 199-207. https://doi.org/10.1016/j.jconrel.2006.02.011
- Choi, S. J., M. Ahn, J. S. Lee and W. J. Jung. 1997. Selection of a high affinity angiogenin-binding peptide from a peptide library displayed on phage coat protein. Mol. Cells 7, 575-581.
- Daniels, T. R., T. Delgado, J. A. Rodriguez, G. Helguera and M. L. Penichet. 2006. The transferrin receptor part I: biology and targeting with cytotoxic antibodies for the treatment of cancer. Clin. Immunol. 121, 144-158. https://doi.org/10.1016/j.clim.2006.06.010
- Daniels, T. R., T. Delgado, G. Helguera and M. L. Penichet. 2006. The transferrin receptor part II: targeted delivery of therapeutic agents into cancer cells. Clin. Immunol. 121, 159-176. https://doi.org/10.1016/j.clim.2006.06.006
- Gomme, P. T. and K. B. McCann. 2005. Transferrin: structure, function and potential therapeutic actions, Drug Discov. Today 10, 267-273. https://doi.org/10.1016/S1359-6446(04)03333-1
- Laske, D. W., R. J. Youle and E. H. Oldfield. 1997. Tumor regression with regional distribution of the targeted toxin TF-CRM107 in patients with malignant brain tumors, Nat. Med. 3, 1362-1368. https://doi.org/10.1038/nm1297-1362
- Liao, W. P., J. DeHaven, J. Shao, J. X. Chen, Y. Rojanasakul, D. L. Lamm and J. K. H. Ma. 1998. Liposomal delivery of alpha-interferon to murine bladder tumor cells via transferrin receptor-mediated endocytosis. Drug Deliv. 5, 111-118. https://doi.org/10.3109/10717549809031386
- Parker, J. 1989. Errors and alternatives in reading the universal genetic code. Microbiol. Rev. 53, 273-298.
- Romanov, V. I. 2003. Phage display selection and evaluation of cancer drug targets. Curr. Cancer Drug Targets 3, 119-129. https://doi.org/10.2174/1568009033482010
- Shadidi, M. and M. Sioud. 2003. Selective targeting of cancer cells using synthetic peptides. Drug Resist Updat. 6, 363-371. https://doi.org/10.1016/j.drup.2003.11.002
- Xu, Z., W. Gu, J. Huang, H. Sui, Z. Zhou, Y. Yang, Z. Yan and Y. Li. 2005. In vitro and in vivo evaluation of actively targetable nanoparticles for paclitaxel delivery. Int. J. Pharm. 288, 361-368. https://doi.org/10.1016/j.ijpharm.2004.10.009
Cited by
- Selection and identification of transferrin receptor-specific peptides as recognition probes for cancer cells pp.1618-2650, 2017, https://doi.org/10.1007/s00216-017-0664-4